Recent advances from the national cancer institute alliance for nanotechnology in cancer

Dorothy Farrell, Joe Alper, Krzystof Ptak, Nicholas J. Panaro, Piotr Grodzinski, Anna D. Barker

Research output: Contribution to journalArticle

55 Scopus citations

Abstract

Nanotechnology will have great impact on how cancer is diagnosed and treated in the future. New technologies to detect and image cancerous changes and materials that enable new methods of cancer treatment will radically alter patient outcomes. The National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer sponsors research in cancer prevention, diagnosis, and therapy and promotes translation of basic science discoveries into clinical practice. The Fourth Annual NCI Alliance Principal Investigator Meeting was held in Manhattan Beach, California October 20-22, 2009. Presented here are highlights from the research presentations at the meeting, in the areas of in vitro diagnostics, targeted delivery of anticancer and contrast enhancement agents, and nanotherapeutics and therapeutic monitoring.

Original languageEnglish (US)
Pages (from-to)589-594
Number of pages6
JournalACS nano
Volume4
Issue number2
DOIs
StatePublished - Feb 23 2010

ASJC Scopus subject areas

  • Materials Science(all)
  • Engineering(all)
  • Physics and Astronomy(all)

Fingerprint Dive into the research topics of 'Recent advances from the national cancer institute alliance for nanotechnology in cancer'. Together they form a unique fingerprint.

  • Cite this

    Farrell, D., Alper, J., Ptak, K., Panaro, N. J., Grodzinski, P., & Barker, A. D. (2010). Recent advances from the national cancer institute alliance for nanotechnology in cancer. ACS nano, 4(2), 589-594. https://doi.org/10.1021/nn100073g